All possibilities - FDA shall investigate and find out the briebe received by FDA Director Howard Sklamberg...
Think with little brain
1. Fresenius could not find any problem with Omontys use in their dialysis centre
2. Amgen was worried about increased sale of Omontys in their last QTRLY report.
You need guts to speak truth, but eventually what is wrong is WRONG by all means.
What AMGN did is totally WRONG !!!